Impact of Different Management Approaches on Clinical Symptoms among Patients with Gastroesophageal Reflux Disease
Abstract
Background: Gastroesophageal reflux disease (GERD) is a common gastrointestinal illness with symptoms of heartburn, chest pain, and regurgitation. Management of GERD could involve proton pump inhibitor (PPI) medications, lifestyle modifications (healthy diet and diaphragmatic breathing exercises), and surgical intervention depending on the patients` condition. Aim: To evaluate the impact of different management approaches on clinical symptoms among patients with gastroesophageal reflux disease. Research design: Nonequivalent quasi experimental research design was utilized in this study. Study Setting: This study was conducted in gastrointestinal unit at kafrelsheikh University Hospital. Study sample: A convenient sample of 90 patients with gastroesophageal reflux disease were divided randomly into 3 groups receiving Proton pump inhibitor (maximum dose), Proton pump inhibitor (medium dose) with lifestyle modifications, and lifestyle modifications only. Tools: Two tools for data collection were used in this study as follow: tool (I) structured interview questionnaire and tool (II) GERD questionnaire which used to assess patients GERD levels in pre, post intervention and follow up stages. Results: the results showed significant decrease in GERD levels among patients receiving PPI, patients receiving PPI with lifestyle modifications, & patients receiving lifestyle modifications only as (X2=24.471&p= 0.001, X2=27.432&p= 0.001 & X2=5.085&p= 0.278) consequently. In addition,…
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.